Cardiovascular and Hematological Disorders - Drug Targets
Impact Factor & Key Scientometrics

Cardiovascular and Hematological Disorders - Drug Targets
Overview

Impact Factor

NA

H Index

45

Impact Factor

1.074

I. Basic Journal Info

Country

United Arab Emirates
Journal ISSN: 1871529X
Publisher: Bentham Science Publishers B.V.
History: 2006-2021
Journal Hompage: Link
How to Get Published:
Find out more

Research Categories

Scope/Description:

CardiovascularHematological DisordersDrug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry pharmacology molecular biology genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins receptors enzymes genes. Each issue of the journal contains a series of indepthmini reviews original research articles drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery identification characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

II. Science Citation Report (SCR)



Cardiovascular and Hematological Disorders - Drug Targets
SCR Impact Factor

Cardiovascular and Hematological Disorders - Drug Targets
SCR Journal Ranking

Cardiovascular and Hematological Disorders - Drug Targets
SCImago SJR Rank

SCImago Journal Rank (SJR indicator) is a measure of scientific influence of scholarly journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from.

Cardiovascular and Hematological Disorders - Drug Targets
Scopus 2-Year Impact Factor Trend

Note: impact factor data for reference only

Cardiovascular and Hematological Disorders - Drug Targets
Scopus 3-Year Impact Factor Trend

Note: impact factor data for reference only

Cardiovascular and Hematological Disorders - Drug Targets
Scopus 4-Year Impact Factor Trend

Note: impact factor data for reference only

Cardiovascular and Hematological Disorders - Drug Targets
Impact Factor History

2-year 3-year 4-year
  • 2023 Impact Factor
    0.851 0.907 0.933
  • 2022 Impact Factor
    1.076 1.151 1.35
  • 2021 Impact Factor
    1.074 1.475 1.433
  • 2020 Impact Factor
    1.534 1.558 1.573
  • 2019 Impact Factor
    1.407 1.478 1.423
  • 2018 Impact Factor
    0.974 1.136 1.424
  • 2017 Impact Factor
    1.132 1.282 1.515
  • 2016 Impact Factor
    1.328 1.69 1.655
  • 2015 Impact Factor
    1.814 1.878 1.72
  • 2014 Impact Factor
    1.776 NA NA
  • 2013 Impact Factor
    1.098 NA NA
  • 2012 Impact Factor
    1.385 NA NA
  • 2011 Impact Factor
    1.215 NA NA
  • 2010 Impact Factor
    1.968 NA NA
  • 2009 Impact Factor
    2.281 NA NA
  • 2008 Impact Factor
    2.404 NA NA
  • 2007 Impact Factor
    2.623 NA NA
  • 2006 Impact Factor
    2.567 NA NA
  • 2005 Impact Factor
    1.9 NA NA
  • 2004 Impact Factor
    1.545 NA NA
  • 2003 Impact Factor
    0.684 NA NA
  • 2002 Impact Factor
    0.25 NA NA
  • 2001 Impact Factor
    0 NA NA
  • 2000 Impact Factor
    NA NA NA
Note: impact factor data for reference only

HIGHEST PAID JOBS

LATEX TUTORIALS

MUST-READ BOOKS

Impact Factor

Impact factor (IF) is a scientometric factor based on the yearly average number of citations on articles published by a particular journal in the last two years. A journal impact factor is frequently used as a proxy for the relative importance of a journal within its field. Find out more: What is a good impact factor?

III. Other Science Influence Indicators

Any impact factor or scientometric indicator alone will not give you the full picture of a science journal. There are also other factors such as H-Index, Self-Citation Ratio, SJR, SNIP, etc. Researchers may also consider the practical aspect of a journal such as publication fees, acceptance rate, review speed. (Learn More)

Cardiovascular and Hematological Disorders - Drug Targets
H-Index

The h-index is an author-level metric that attempts to measure both the productivity and citation impact of the publications of a scientist or scholar. The index is based on the set of the scientist's most cited papers and the number of citations that they have received in other publications

45

Cardiovascular and Hematological Disorders - Drug Targets
H-Index History

scijournal.org is a platform dedicated to making the search and use
of impact factors of science journals easier.

Copyright 2012-2024 scijournal.org